Trinity Biotech (TRIB) Income from Continuing Operations (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Income from Continuing Operations of 15212000.0 for Q4 2024, down 176.18% year-on-year from 19968469.02 in Q1 2024, and down 215.01% on a QoQ basis from 4829000.0 in Q3 2024.
Trinity Biotech (TRIB) Income from Continuing Operations (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Income from Continuing Operations for 16 consecutive years, with 15212000.0 the latest figure, recorded in Q4 2024.
- Quarterly Income from Continuing Operations fell 176.18% year-over-year to 15212000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 30243000.0 (up 18.24% YoY) and the FY2025 annual result came in at 37376000.0, down 19.73% from the prior year.
- Income from Continuing Operations fell to 15212000.0 in Q4 2024 per TRIB's latest filing, from 4829000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for TRIB reached as high as 8260000.0 in Q3 2020 and fell as low as 18880000.0 in Q2 2023.
- A 5-year average of 5498550.0 and a median of 5892000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2020 — Income from Continuing Operations surged 2441.54% — and 2022, when it slumped 2032.07%.
- Year by year, Income from Continuing Operations stood at 15011000.0 in 2020, then soared by 75.9% to 3617000.0 in 2021, then plunged by 188.69% to 10442000.0 in 2022, then surged by 47.25% to 5508000.0 in 2023, then sank by 176.18% to 15212000.0 in 2024.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 15212000.0, 4829000.0, and 7019000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -15.21 Mn |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -7.02 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -5.51 Mn |
| Sep 30, 2023 | -6.28 Mn |
| Jun 30, 2023 | -18.88 Mn |
| Mar 31, 2023 | -6.33 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -9.99 Mn |
| Jun 30, 2022 | -10.18 Mn |
| Mar 31, 2022 | -13.37 Mn |
| Dec 31, 2021 | -3.62 Mn |
| Sep 30, 2021 | 1.85 Mn |
| Jun 30, 2021 | 527,000.00 |
| Mar 31, 2021 | 4.39 Mn |
| Dec 31, 2020 | -15.01 Mn |
| Sep 30, 2020 | 8.26 Mn |
| Jun 30, 2020 | 1.76 Mn |
| Mar 31, 2020 | 3.09 Mn |